Product Name

  • Name

    Atorvastatin lactone

  • EINECS
  • CAS No. 125995-03-1
  • Article Data21
  • CAS DataBase
  • Density 1.24 g/cm3
  • Solubility
  • Melting Point 103-106 °C
  • Formula C33H33FN2O4
  • Boiling Point 674.8 °C at 760 mmHg
  • Molecular Weight 540.634
  • Flash Point 361.9 °C
  • Transport Information
  • Appearance slightly yellow solid
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 125995-03-1 (Atorvastatin lactone)
  • Hazard Symbols
  • Synonyms 1H-Pyrrole-3-carboxamide,5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-,(2R-trans)-;5-(4-Fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydropyran-2-yl]ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylicacid phenylamide;Atorvastatin d-lactone;5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide;
  • PSA 80.56000
  • LogP 6.86650

Synthetic route

pentan-1-ol
71-41-0

pentan-1-ol

lipitor
134523-03-8

lipitor

A

pentyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

pentyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 96%
B n/a
1-[2-((2R,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)ethyl]-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide
842163-03-5

1-[2-((2R,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)ethyl]-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With manganese(IV) oxide In acetone at 25℃; for 24h;95%
With Dess-Martin periodane In dichloromethane at 20℃; for 2.5h;
2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid
581772-29-4

2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With camphor-10-sulfonic acid In tetrahydrofuran at 20℃; for 3h;90%
lipitor
134523-03-8

lipitor

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Stage #1: lipitor With hydrogenchloride In water; ethyl acetate at 4 - 20℃;
Stage #2: In toluene for 2.5h; Reflux; Dean-Stark;
88%
With hydrogenchloride In water at 20℃; for 2h;55%
Stage #1: lipitor With hydrogenchloride In dichloromethane; water
Stage #2: With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; Cooling with ice;
2.78 g
(3R,5R)-methyl 3,5-bis((tert-butyldimethylsilyl)oxy)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)heptanoate

(3R,5R)-methyl 3,5-bis((tert-butyldimethylsilyl)oxy)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)heptanoate

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; water at 20℃; stereoselective reaction;75%
2-methyl-propan-1-ol
78-83-1

2-methyl-propan-1-ol

lipitor
134523-03-8

lipitor

A

isobutyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

isobutyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 74%
B n/a
propan-1-ol
71-23-8

propan-1-ol

lipitor
134523-03-8

lipitor

A

propyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

propyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 70%
B n/a
n-heptan1ol
111-70-6

n-heptan1ol

lipitor
134523-03-8

lipitor

A

heptyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

heptyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 68%
B n/a
lipitor
134523-03-8

lipitor

hexan-1-ol
111-27-3

hexan-1-ol

A

hexyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

hexyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 66%
B n/a
lipitor
134523-03-8

lipitor

nonyl alcohol
143-08-8

nonyl alcohol

A

nonyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

nonyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 66%
B n/a
lipitor
134523-03-8

lipitor

A

(S)-5-(4-fluorophenyl)-2-isopropyl-1-(2-(6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide
442851-50-5

(S)-5-(4-fluorophenyl)-2-isopropyl-1-(2-(6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With hydrogenchloride In water for 4h; Reflux;A 14%
B 65%
lipitor
134523-03-8

lipitor

isopropyl alcohol
67-63-0

isopropyl alcohol

A

(3R,5R)-isopropyl 7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate
1035205-25-4

(3R,5R)-isopropyl 7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 54%
B n/a
atorvastatin
134523-00-5

atorvastatin

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
In toluene at 60℃; for 40h;46%
hydrogenchloride In toluenen/a
In toluene for 4h; Product distribution / selectivity; Heating / reflux;
In hexane for 6h; Heating;3.9 g
2,2-dimethyl-propanol-1
75-84-3

2,2-dimethyl-propanol-1

lipitor
134523-03-8

lipitor

A

neopentyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

neopentyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

B

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
With sulfuric acid at 0 - 20℃; for 2.58333h;A 44%
B n/a
1,1-dimethylethyl (R)-7-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-5-hydroxy-3-oxo-1-heptanoate
134394-98-2

1,1-dimethylethyl (R)-7-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-5-hydroxy-3-oxo-1-heptanoate

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Yield given. Multistep reaction;
(+/-)-trans-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-<2-tetrahydro-4-hydroxy-6-oxo-2H-pyran-6-yl)ethyl>-1H-pyrrole-3-carboxamide
110862-39-0, 125995-03-1, 134523-07-2

(+/-)-trans-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-<2-tetrahydro-4-hydroxy-6-oxo-2H-pyran-6-yl)ethyl>-1H-pyrrole-3-carboxamide

A

atorvastatin lactone
125995-03-1

atorvastatin lactone

B

(-)-(4S)-trans-2-(4-fluorophenyl)-5-(1-methylethyl)-N,3-diphenyl-1-<(tetrahydro-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl>-1H-pyrrole-4-carboxamide
134523-07-2

(-)-(4S)-trans-2-(4-fluorophenyl)-5-(1-methylethyl)-N,3-diphenyl-1-<(tetrahydro-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl>-1H-pyrrole-4-carboxamide

Conditions
ConditionsYield
Yield given. Yields of byproduct given;
methanol
67-56-1

methanol

atorvastatin
134523-00-5

atorvastatin

A

atorvastatin lactone
125995-03-1

atorvastatin lactone

B

(3R,5R)-methyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate
345891-62-5

(3R,5R)-methyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

Conditions
ConditionsYield
With phosphoric acid In acetonitrile at 80℃; for 3h;A 15.2 mg
B 6.9 mg
ethyl α-bromo-4-fluorobenzeneacetate

ethyl α-bromo-4-fluorobenzeneacetate

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 82.5 percent / triethylamine / acetonitrile / Ambient temperature
2: triethylamine / CH2Cl2 / 1 h / 0 °C
3: NaOH / methanol; H2O / 2 h / Heating
4: 43 percent / acetic anhydride / 4 h / 90 °C
5: 1.) concd. HCl, 2.) p-TSA, H2O / 1.) ethanol, reflux, 24 h, 2.) acetone, reflux, 2 d
6: 1.) sodium hydride, n-butyllithium / 1.) THF, hexane, 0 deg C, 30 min, 2.)a) -78 deg C, 30 min, b) 0 deg C, 1 h
7: 1.) tributylborane, sodium borohydride, 2.) 3 N NaOH, 30percent H2O2 / 1.) THF, a) RT, b) 0 deg C, 3 h, 2.) RT
8: toluene / 6 h / Heating
View Scheme
ethyl 3-(4-cyanophenyl)propiolate
143952-58-3

ethyl 3-(4-cyanophenyl)propiolate

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
2: 73.9 g / methanol; tetrahydrofuran / 0 °C
3: 73 g / diisopropylamine, n-butyllithium / tetrahydrofuran; hexane / 4 h / -70 °C
View Scheme
ethyl α-<<2-(1,3-dioxolan-2-yl)ethyl>amino>-4-fluorobenzeneacetate

ethyl α-<<2-(1,3-dioxolan-2-yl)ethyl>amino>-4-fluorobenzeneacetate

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: triethylamine / CH2Cl2 / 1 h / 0 °C
2: NaOH / methanol; H2O / 2 h / Heating
3: 43 percent / acetic anhydride / 4 h / 90 °C
4: 1.) concd. HCl, 2.) p-TSA, H2O / 1.) ethanol, reflux, 24 h, 2.) acetone, reflux, 2 d
5: 1.) sodium hydride, n-butyllithium / 1.) THF, hexane, 0 deg C, 30 min, 2.)a) -78 deg C, 30 min, b) 0 deg C, 1 h
6: 1.) tributylborane, sodium borohydride, 2.) 3 N NaOH, 30percent H2O2 / 1.) THF, a) RT, b) 0 deg C, 3 h, 2.) RT
7: toluene / 6 h / Heating
View Scheme
α-<<2-(1,3-dioxolan-2-yl)ethyl>(2-methyl-1-oxopropyl)amino>-4-fluorobenzeneacetic acid
110862-44-7

α-<<2-(1,3-dioxolan-2-yl)ethyl>(2-methyl-1-oxopropyl)amino>-4-fluorobenzeneacetic acid

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 43 percent / acetic anhydride / 4 h / 90 °C
2: 1.) concd. HCl, 2.) p-TSA, H2O / 1.) ethanol, reflux, 24 h, 2.) acetone, reflux, 2 d
3: 1.) sodium hydride, n-butyllithium / 1.) THF, hexane, 0 deg C, 30 min, 2.)a) -78 deg C, 30 min, b) 0 deg C, 1 h
4: 1.) tributylborane, sodium borohydride, 2.) 3 N NaOH, 30percent H2O2 / 1.) THF, a) RT, b) 0 deg C, 3 h, 2.) RT
5: toluene / 6 h / Heating
View Scheme
α-<<2-(1,3-dioxolan-2-yl)ethyl>(2-methyl-1-oxopropyl)amino>-4-fluorobenzeneacetic acid, ethyl ester
110862-43-6

α-<<2-(1,3-dioxolan-2-yl)ethyl>(2-methyl-1-oxopropyl)amino>-4-fluorobenzeneacetic acid, ethyl ester

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: NaOH / methanol; H2O / 2 h / Heating
2: 43 percent / acetic anhydride / 4 h / 90 °C
3: 1.) concd. HCl, 2.) p-TSA, H2O / 1.) ethanol, reflux, 24 h, 2.) acetone, reflux, 2 d
4: 1.) sodium hydride, n-butyllithium / 1.) THF, hexane, 0 deg C, 30 min, 2.)a) -78 deg C, 30 min, b) 0 deg C, 1 h
5: 1.) tributylborane, sodium borohydride, 2.) 3 N NaOH, 30percent H2O2 / 1.) THF, a) RT, b) 0 deg C, 3 h, 2.) RT
6: toluene / 6 h / Heating
View Scheme
5-(4-fluorophenyl)-2-(1-methylethyl)-1-(3-oxopropyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide
110862-46-9

5-(4-fluorophenyl)-2-(1-methylethyl)-1-(3-oxopropyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) sodium hydride, n-butyllithium / 1.) THF, hexane, 0 deg C, 30 min, 2.)a) -78 deg C, 30 min, b) 0 deg C, 1 h
2: 1.) tributylborane, sodium borohydride, 2.) 3 N NaOH, 30percent H2O2 / 1.) THF, a) RT, b) 0 deg C, 3 h, 2.) RT
3: toluene / 6 h / Heating
View Scheme
1-<2-(1,3-dioxolan-2-yl)ethyl>-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide
110862-45-8

1-<2-(1,3-dioxolan-2-yl)ethyl>-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 1.) concd. HCl, 2.) p-TSA, H2O / 1.) ethanol, reflux, 24 h, 2.) acetone, reflux, 2 d
2: 1.) sodium hydride, n-butyllithium / 1.) THF, hexane, 0 deg C, 30 min, 2.)a) -78 deg C, 30 min, b) 0 deg C, 1 h
3: 1.) tributylborane, sodium borohydride, 2.) 3 N NaOH, 30percent H2O2 / 1.) THF, a) RT, b) 0 deg C, 3 h, 2.) RT
4: toluene / 6 h / Heating
View Scheme
methyl (R)-(+)-5-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-3-hydroxy-1-pentanoate
134394-97-1

methyl (R)-(+)-5-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-3-hydroxy-1-pentanoate

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 73 g / diisopropylamine, n-butyllithium / tetrahydrofuran; hexane / 4 h / -70 °C
View Scheme
(R*,R*)-3,5-dihydroxy-7-<(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-1-heptanoic acid
125971-63-3

(R*,R*)-3,5-dihydroxy-7-<(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-1-heptanoic acid

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene / 6 h / Heating
View Scheme
methyl 7-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-5-hydroxy-3-oxo-1-heptanoate
110862-47-0

methyl 7-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-5-hydroxy-3-oxo-1-heptanoate

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) tributylborane, sodium borohydride, 2.) 3 N NaOH, 30percent H2O2 / 1.) THF, a) RT, b) 0 deg C, 3 h, 2.) RT
2: toluene / 6 h / Heating
View Scheme
*,S*)>-5-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-3-hydroxy-1-pentanoic acid, 2-hydroxy-1,2,2-triphenylethyl ester
134394-96-0

*,S*)>-5-<2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-<(phenylamino)carbonyl>-1H-pyrrol-1-yl>-3-hydroxy-1-pentanoic acid, 2-hydroxy-1,2,2-triphenylethyl ester

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 73.9 g / methanol; tetrahydrofuran / 0 °C
2: 73 g / diisopropylamine, n-butyllithium / tetrahydrofuran; hexane / 4 h / -70 °C
View Scheme
[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; ammonium salt
340266-37-7

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; ammonium salt

atorvastatin lactone
125995-03-1

atorvastatin lactone

Conditions
ConditionsYield
In toluene for 12h; Heating / reflux;
atorvastatin lactone
125995-03-1

atorvastatin lactone

1-((3R,5R)-3,5-dihydroxy-7-(hydroxyamino)-7-oxoheptyl)-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-7H-pyrrole-3-carboxamide
1174332-81-0

1-((3R,5R)-3,5-dihydroxy-7-(hydroxyamino)-7-oxoheptyl)-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-7H-pyrrole-3-carboxamide

Conditions
ConditionsYield
With hydroxylamine In tetrahydrofuran; water for 48h;99%
With magnesium(II) bromide; hydroxylamine hydrochloride; sodium hydrogencarbonate In tetrahydrofuran; methanol at 20℃; for 20h;51%
atorvastatin lactone
125995-03-1

atorvastatin lactone

tetraethyl 3-aminopropylidene-1,1-bisphosphonate
141473-49-6

tetraethyl 3-aminopropylidene-1,1-bisphosphonate

tetraethyl (3R,5R)-3-N-(7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoyl)aminopropane-1,1-bisphosphonate
1040395-59-2

tetraethyl (3R,5R)-3-N-(7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoyl)aminopropane-1,1-bisphosphonate

Conditions
ConditionsYield
In tetrahydrofuran at 60℃; for 48h;96.3%
atorvastatin lactone
125995-03-1

atorvastatin lactone

lipitor
134523-03-8

lipitor

Conditions
ConditionsYield
Stage #1: atorvastatin lactone With calcium hydroxide In tetrahydrofuran; water at 45 - 50℃; for 2h;
Stage #2: In dichloromethane; di-isopropyl ether at 10 - 15℃; for 0.25h; Product distribution / selectivity;
95.1%
Stage #1: atorvastatin lactone With sodium hydroxide In methanol; water at 25 - 50℃; for 2h;
Stage #2: With hydrogenchloride In water pH=7.8 - 8.2;
Stage #3: With calcium acetate In methanol; water at 25 - 30℃; Product distribution / selectivity;
92.21%
Stage #1: atorvastatin lactone With calcium hydroxide In tetrahydrofuran; water at 45 - 50℃; for 2h;
Stage #2: In methanol at 40 - 45℃; Product distribution / selectivity;
91.82%
atorvastatin lactone
125995-03-1

atorvastatin lactone

1-[2-((2R,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)ethyl]-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide
842163-03-5

1-[2-((2R,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)ethyl]-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide

Conditions
ConditionsYield
Stage #1: atorvastatin lactone With diisobutylaluminium hydride In dichloromethane; toluene at -78℃; for 1h;
Stage #2: With water; rochelle salt In dichloromethane; toluene at 20℃; Product distribution / selectivity;
95%
calcium acetate hydrate
114460-21-8

calcium acetate hydrate

atorvastatin lactone
125995-03-1

atorvastatin lactone

2C33H36FN2O5(1-)*Ca(2+)

2C33H36FN2O5(1-)*Ca(2+)

Conditions
ConditionsYield
Stage #1: atorvastatin lactone With sodium hydroxide In methanol; tert-butyl methyl ether; water at 50℃; for 2h;
Stage #2: calcium acetate hydrate In water at 30 - 50℃; for 4.5h; Heating;
94%
atorvastatin lactone
125995-03-1

atorvastatin lactone

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(2R,4R)-1-{2-[4-(tert-butyldimethylsilyloxy)-6-oxotetrahydro-2-pyranyl]-ethyl}-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
842162-99-6

(2R,4R)-1-{2-[4-(tert-butyldimethylsilyloxy)-6-oxotetrahydro-2-pyranyl]-ethyl}-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide92%
strontium hydroxide
1311-10-0

strontium hydroxide

strontium(II) acetate
543-94-2

strontium(II) acetate

atorvastatin lactone
125995-03-1

atorvastatin lactone

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate strontium pentahydrate

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate strontium pentahydrate

Conditions
ConditionsYield
Stage #1: strontium hydroxide; atorvastatin lactone With water In tert-butyl methyl ether; acetone at 20℃; for 3.5h;
Stage #2: strontium(II) acetate With water In acetone at 50℃; for 10h; Product distribution / selectivity;
85%
atorvastatin lactone
125995-03-1

atorvastatin lactone

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate strontium

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate strontium

Conditions
ConditionsYield
Stage #1: atorvastatin lactone With strontium hydroxide In tert-butyl methyl ether; water; acetone at 20℃;
Stage #2: With strontium(II) acetate In water; acetone at 50℃; Product distribution / selectivity;
85%
strontium hydroxide
1311-10-0

strontium hydroxide

strontium(II) acetate
543-94-2

strontium(II) acetate

atorvastatin lactone
125995-03-1

atorvastatin lactone

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate strontium

[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate strontium

Conditions
ConditionsYield
Stage #1: strontium hydroxide; atorvastatin lactone In methanol; tert-butyl methyl ether; water at 20℃; for 3.5h;
Stage #2: strontium(II) acetate In methanol; tert-butyl methyl ether; water at 50℃; for 19h;
77%
atorvastatin lactone
125995-03-1

atorvastatin lactone

calcium chloride

calcium chloride

atorvastatin calcium

atorvastatin calcium

Conditions
ConditionsYield
Stage #1: atorvastatin lactone With methanol; sodium hydroxide; water
Stage #2: calcium chloride In water
77%
atorvastatin lactone
125995-03-1

atorvastatin lactone

(R)-2-[(2-aminoethoxy)methyl]4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester
103129-81-3

(R)-2-[(2-aminoethoxy)methyl]4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester

(R)-3-ethyl-5-methyl-2-{[2-({7-[(3-anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl}amino)ethoxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate

(R)-3-ethyl-5-methyl-2-{[2-({7-[(3-anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl}amino)ethoxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate

Conditions
ConditionsYield
In ethanol for 18h; Heating / reflux;76%
atorvastatin lactone
125995-03-1

atorvastatin lactone

(2R,4R)-1-{2-[4-(tert-Butyldimethylsilyloxy)-6-oxotetrahydro-2-pyranyl]-ethyl}-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide

(2R,4R)-1-{2-[4-(tert-Butyldimethylsilyloxy)-6-oxotetrahydro-2-pyranyl]-ethyl}-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide

Conditions
ConditionsYield
With 1H-imidazole; tert-butyldimethylsilyl chloride In DMF (N,N-dimethyl-formamide) at 20℃; for 6h;73%
atorvastatin lactone
125995-03-1

atorvastatin lactone

1-((3R,5R)-7-amino-3,5-dihydroxy-7-oxoheptyl)-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide

1-((3R,5R)-7-amino-3,5-dihydroxy-7-oxoheptyl)-5-(4-fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide

Conditions
ConditionsYield
With ammonia In methanol at 20℃; for 24h;71%
atorvastatin lactone
125995-03-1

atorvastatin lactone

amlodipine
103129-82-4

amlodipine

(S)-3-ethyl-5-methyl-2-{[2-({7-[(3-anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl}amino)ethoxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate

(S)-3-ethyl-5-methyl-2-{[2-({7-[(3-anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl}amino)ethoxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate

Conditions
ConditionsYield
In ethanol for 18h; Heating / reflux;64%
atorvastatin lactone
125995-03-1

atorvastatin lactone

tetraethyl (aminomethylene)bis(phosphonate)
80474-99-3

tetraethyl (aminomethylene)bis(phosphonate)

tetraethyl [(3R,5R)-(7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoyl)aminomethylene]bisphosphonate
1040395-64-9

tetraethyl [(3R,5R)-(7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoyl)aminomethylene]bisphosphonate

Conditions
ConditionsYield
In tetrahydrofuran at 60℃; for 48h;62.3%

Atorvastatin lactone Chemical Properties

Molecular structure of Atorvastatin lactone (CAS NO.125995-03-1) is:

Product Name: Atorvastatin lactone
CAS Registry Number: 125995-03-1
IUPAC Name: 5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide
Molecular Weight: 540.624523 [g/mol]
Molecular Formula: C33H33FN2O4
XLogP3-AA: 5.7
H-Bond Donor: 2
H-Bond Acceptor: 5
Melting Point: 103-106 °C
Molar Volume: 435.4 cm3
Surface Tension: 45.3 dyne/cm
Density: 1.24 g/cm3
Flash Point: 361.9 °C
Enthalpy of Vaporization: 104.1 kJ/mol
Boiling Point: 674.8 °C at 760 mmHg
Vapour Pressure: 3.92E-19 mmHg at 25°C

Atorvastatin lactone Uses

 Atorvastatin lactone (CAS NO.125995-03-1) can be used for the treatment of inflammation.

Atorvastatin lactone Specification

 Atorvastatin lactone , its cas register number is 125995-03-1. It also can be called 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)- ; (4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one .It is a slightly yellow solid.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View